A B S T R A C T Polymorphonuclear leukocytes
INTRODUCTION
Proteinases released into the extracellular space by stimulated neutrophils (PMN)' have the potential to produce tissue injury. PMN elastase (human leukocyte elastase; HLE) has attracted particular attention in this regard because of its putative role in the pathogenesis of pulmonary emphysema (I, 2) , and also because of the wide range of other connective tissue proteins HLE degrades (3) (4) (5) (6) (7) .
The Recent evidence from several laboratories indicates that the elastase inhibitory capacity (EIC) of a1-proteinase inhibitor (a1PI) is lost when this inhibitor is exposed to oxidants (8) (9) (10) (11) (12) (13) (14) . Because stimulated PMN are a source of oxidant activity, it has been proposed that PMN may decrease the local EIC of a1PI. Recent work indicates that oxidative inactivation of a1PI by stimulated PMN may occur in vitro (15) (16) (17) . These data suggested that PMN may create a local environment in which HLE is present in relative excess to nonoxidized a1PI. Under such conditions, the released HLE would be able to produce connective tissue injury.
We have developed a model system similar to that described by Varani et al. (18) to clarify the potential of PMN to produce connective tissue injury in the presence of proteinase inhibitors. Stimulated PMN are held in short-term culture in close proximity to radiolabeled human plasma fibronectin (FN), an extremely proteinase-sensitive substrate (19) . Proteolytic activity is readily quantified, and proteinase inhibitors can be included in the test system.
In this report, we demonstrate that oxidants released from stimulated neutrophils do not protect their released proteinases from inhibition by al-PI or a2-macroglobulin (a2M). However, close contact between neutrophils and substrate results in proteolysis even in the presence of an excess of proteinase inhibitors. These results suggest that propinquity of stimulated PMN to susceptible macromolecules may result in proteolysis in vivo.
METHODS
Reagents. Phorbol myristate acetate (PMA), zymosan, dimethyl sulfoxide (DMSO), bovine serum albumin (BSA, Cohn fraction V, A-4503), and phenylmethylsulfonylfluoride (PMSF) were purchased from Sigma Chemical Co., St. Louis, MO. All other chemicals were reagent grade.
Enzymes and enzyme inhibitors. HLE was purified from human sputum, utilizing Trasylol-Sepharose and ion-exchange chromatography (20, 21) , then lyophilized and stored at -20°C. The concentration of HLE in solution was based upon the extinction coefficient for the absorbance at 280 mm of a 1% solution (E9) of 9.85 (22) .
Human neutrophil myeloperoxidase (MPO) was purified from PMN obtained by leukapheresis of a normal donor (23 Enzyme assays. Elastase-like amidase activity (25) was measured with methoxysuccinyl-alanine-alanine-proline-valine-p-nitroanilide (MSAPN), obtained from Dr. J. C. Powers, Georgia Institute of Technology, Atlanta, GA. The elastase activity of supernatant fluids from PMN was assessed by the rate of change in optical density at 410 nm (DU-8 spectrophotometer, Beckman Instruments, Fullerton, CA) at 37°C in phosphate-buffered saline (PBS: 50 mM phosphate, 150 mM NaCl, pH 7.4), and compared to the activity of purified HLE.
Assays for lysozyme (26) , superoxide anion (27) , and LDH (28) were performed according to published techniques.
PMN. Human PMN were separated from heparinized blood by Ficoll-Hypaque centrifugation (29) . Residual erythrocytes were lysed with a cold solution of 0.15 M NH4C1, 10 mM KHCO3, and 1 mM sodium EDTA, pH 7.2. The PMN were washed with RPMI 1640 medium and held at 4°C until used in the assays. Differential counting of cells deposited on glass slides with a cytocentrifuge (Cytospin, Shandon Southern Instrument Co., Sewickley, PA) and stained with Wright's stain revealed 295% PMN. In studies requiring stimulated neutrophils, either PMA (final concentration, 10 ng/ml) or zymosan opsonized with fresh human serum (1 mg/ml) was added to the assay mixture at the appropriate time.
Assay of proteolytic activity using '251-labeled FN. Plasma FN was purified from outdated human plasma (The Blood Bank of The Jewish Hospital of St. Louis, MO) as described (3), using lysine-Sepharose, gelatin-Sepharose, and DEAEcellulose chromatography. The FN was dialyzed against 0.05 M Tris-HCI, pH 7.4, adjusted to 1 mg/ml using a value of E`of 12.8 (30) , and stored at -70°C in small aliquots.
FN was labeled with 1251 using Enzymobeads as described in Bio-Rad Product Information 1060 (Bio-Rad Laboratories, Richmond, CA). The radiolabeling reaction mixture, contained in a 6 X 50-mm glass tube, included -1 mCi carrierfree '25I-NaI (New England Nuclear, Boston, MA) in 10,ul, 25 ,l of FN solution (at least 1 mg/ml), 25 ul of 1.0 M sodium phosphate buffer (pH 7.2), 25 Al of fresh 1% fl-D-glucose and of 25 Ml of hydrated Enzymobead suspension. After 30 min at room temperature, the contents of the tube were removed and desalted using a Sephadex G-25 column, 1 X 5 cm, equilibrated with PBS containing 1 mg/ml bovine serum albumin. Greater than 90% of the 1251 in the radiolabeled FN was precipitable by 5% trichloracetic acid and by rabbit antibody raised to purified FN. In addition, >90% of the 1251 in radiolabeled FN binds to gelatin, as would be expected for intact FN.
To prepare microtiter plates for proteinase assays, '25I-FN was diluted with unlabeled FN to yield 1,000-2,000 cpm/ Mg. 6 Inactivation of ajPI by exogenous MPO and superoxide anion. Oxidative inactivation of a1PI would be expected to result in an increased expression of proteolytic activity of PMN (due to loss of EIC of the inhibitor). To confirm that oxidative inactivation of a1PI by PMN occurred under conditions described by others, and to ensure that loss of EIC was detectable by our test system, we studied the effect of addition of purified MPO and an enzymatic superoxide-generating system (xanthine and xanthine oxidase).
MPO (16 mU/ml) plus H202 (10 ,M), or xanthine (50 AM) plus xanthine oxidase (0.6 ,uM), as described previously (16, 17) , were added to coated microtiter wells that contained 325 ng alPI and PMA (final concentration, 10 ng/ml) in RPMI-1640 salts. After a 30-min incubation at 370C in 5% CO2 in air, 30,000 PMN were added. Control wells received either no a1PI or no oxidants. After a 3-h incubation in the CO2 incubator, the solubilized 125I was determined.
RESULTS
Effect of nonproteolytic proteins and pH on the release of 1251-peptides from '25I-FN. After a 3-h incubation at 370C with PBS, followed by drying, -40% (14 ug) of the 1251-FN remained adherent to the microtiter wells. It released by 30,000 PMN,  Fig. 3) . Therefore, to provide maximum sensitivity for detecting inhibitor inactivation, 325 ng a1PI was tested for its ability to inhibit the proteolytic activity of 30,000 PMN. Alpha1PI inhibited 79.8±6.3 (SD)% of the PMN-derived proteolytic activity (Fig. 3) .
Addition of catalase, SOD, or DMSO to the assays, to catalytically degrade or scavenge hydrogen peroxide, superoxide anion, or hydroxyl radical, respectively, did not significantly increase the inhibitory capacity of the aIPI toward PMN-derived proteolytic activity (Fig. 3 ). Although stimulated PMN should themselves be a source of sufficient hydrogen peroxide, as a result of spontaneous or enzymatic dismutation of superoxide anion (27) , to serve as a substrate for catalytic activity of MPO, we tested the effect of exogenous hydrogen peroxide on the test system. No increase in proteolysis was observed (Fig. 3 ).
When the inhibition by a1PI of PMN-derived proteolytic activity was compared with its inhibition of HLE having comparable enzymatic activity, the inhibition of PMN-derived proteolytic activity was less (P < 0.001, t test; Fig. 3 ). This observation demonstrated that a1PI inhibited elastase derived from viable PMN (when the cells were in contact with the substrate) less well than it inhibited purified HLE.
Although the amount of a1PI used in the experiments shown in Fig. 3 was carefully chosen (see above), three additional concentrations were tested in each experiment. The results were qualitatively unchanged regardless of inhibitor concentration used: PMN-de- h. In marked contrast, when the a1PI was exposed to 16 mU/ml MPO or exogenous superoxide anion (50 MM xanthine plus 0.6 MAM xanthine oxidase) for 30 min before addition of PMN, the FN solubilization observed was 3.75±1.33 and 3.93±0.13 ,g, respectively (P < 0.01 for both comparisons, t test). The FN solubilization when the a1PI was incubated with oxidants was not significantly different from that observed in the absence of a1PI (Fig. 2) , indicating complete loss of the EIC of a1PI under these conditions, as reported by others (16, 17) .
Thus, the lack of inactivation of aLPI by stimulated PMN alone was not due to inability of the FN plate test system to detect loss of EIC by oxidant-exposed a1PI.
Inhibition of PMN-derived proteolytic activity by a2M. Preliminary experiments revealed that 3.54 Mg of a2M was just sufficient to completely inhibit the activity of 25 ng of HLE (Fig. 4) . Accordingly, this amount of a2M was used in experiments examining inhibition of PMN-derived proteolytic activity, for reasons outlined above; 73.5±12.0% of the proteolytic activity was inhibited (Fig. 4) . As with ajPI, the presence of catalase, SOD, and exogenously added hydrogen peroxide failed to alter the observed inhibition.
Less inhibition of PMN-derived proteolytic activity than of HLE was observed (P < 0.001, t test; Fig. 4) .
Two additional concentrations of a2M were also tested in each experiment. The results (n = 10, each group), expressed as percent inhibition of PMN-derived proteolysis±SD for each amount of a2M, are as follows: 14.2 Ag, 80.8+12.1%; 3.54 Ag, 73.4±12.0%; and 884 ng, 51.1±17.3%. These findings are similar to those for alPI. DISCUSSION The model system described in this report has permitted the rapid, accurate quantification of proteolysis by a few thousand PMN when placed in contact with a substrate that is extremely sensitive to proteolytic degradation. Although the substrate used ('25I-labeled FN) is sensitive to a variety of proteinases as previously reported and confirmed here, it was evident that nearly all of the FN proteolytic activity from stimulated PMN resulted from released HLE. Our test system mimics the in vivo situation to the extent that (a) stimulated PMN were examined at physiologic temperature, pH, and salt concentrations; (b) the inhibitors and cells tested were all of human origin; and (c) the PMN were in close proximity to a connective tissue substrate.
The model system reported here has enabled in vitro study of the hypothesis that PMN-derived oxidants increase the local vulnerability of tissues to proteinases released by PMN by oxidatively inactivating proteinase inhibitors in the cellular microenvironment. Pre- (14), superoxide anion (33) , and hydroxyl radical (34) ; and (c) stimulated PMN, when incubated with a1PI, reduce its EIC (15) (16) (17) . Earlier in vitro experiments that examined the possibility that PMN-derived oxidants inactivate a1PI quantified the loss of EIC of a1PI in PMN supernatant fluids by gel filtration or elastase assay, using porcine pancreatic elastase, not HLE. In contrast to pancreatic elastase, HLE binds to oxidized a1PI with lowered affinity. Matheson et al. allude to difficulties in studying the interaction of oxidized a1PI with HLE because the enzyme could either form a complex with the oxidized a1PI or convert it to a modified form (14) . The activity of released PMN proteinases was not examined in the previous studies of inactivation of a1PI by PMN.
Stimulated PMN do appear to oxidatively inactivate a1PI under some conditions (15) (16) (17) . The most convincing lines of evidence in this regard have been the reduction in a1PI inactivation in the presence of antagonists of neutrophil oxidants, the lack of inactivation of a1PI by oxidant-deficient neutrophils (derived from patients with chronic granulomatous disease or hereditary MPO deficiency), and the partial restoration of lost EIC by reducing agents. Neutrophil-derived oxidants were thought to be responsible for oxidized a1PI found in rheumatoid synovial fluid (35) .
Since our test system readily detected loss of EIC by a1PI when it was exposed to exogenously added myeloperoxidase and superoxide anion, we were initially surprised to find that a1PI in limited quantities substantially inhibited elastase activity from stimulated PMN (PMA or opsonized zymosan), and that the observed inhibition was not altered by addition of reagents that reduce (SOD, catalase, and DMSO) or enhance (hydrogen peroxide) the activity of PMN-derived oxidants. Similar results were obtained with the other major circulating elastase inhibitor, a2M, confirming that a2M was not susceptible to oxidative inactivation under the conditions tested (17) .
Under the conditions tested, we have found no evidence that PMN-derived oxidants potentiated FN proteolysis in the presence of proteinase inhibitors. It is important to note that our work does not conflict with data indicating that cigarette smoke oxidants are capable of inactivating proteinase inhibitors (8, 9, 36, 37) . It also does not indicate that PMN-derived oxidants are unable to inactivate a1PI (exogenously supplied MPO and superoxide anion did inactivate a1PI in our system).
While searching for the explanation for the lack of oxidant-mediated enhancement of PMN-derived elastase activity in the presence of a1PI, we developed an appreciation for the complex dynamics of PMN degranulation in a microenvironment in which the cells are closely applied to a proteinase-sensitive substrate, but bathed in proteinase inhibitors. Many variables that would not influence the results of previous experiments became critically important in our test system. These include (a) the timing of release of oxidants in relation to the release of proteinases from the PMN, since oxidants prevent binding of a1PI to proteinases but do not dissociate proteinase-a,PI complexes once formed (unpublished observations); (b) the concentration of PMN (since inhibition of PMN-derived elastase is stoichiometric, while inactivation of a1PI may be both stoichiometric, in the case of reactive oxygen species, or catalytic, in the case of MPO); and (c) the area of contact between the PMN and the substrate, from which proteinase inhibitors may be partially excluded. The possibility that inhibitor oxidation by stimulated PMN might be prevented by interfering substances such as free methionine (17) in the RPMI medium was excluded by the lack of ajPI inactivation by stimulated PMN when the assay was performed in a medium containing only RPMI salts, glucose, and bicarbonate (unpublished observations). It is noteworthy that oxidation of ajPI by MPO is optimized by acid pH (6.2) and low ionic strength (14) , as opposed to the relatively physiologic conditions used in our studies. It is also interesting to speculate that PMN contain an enzymatic activity capable of reducing protein-bound methionine sulfoxide, as has been described for other mammalian tissues (38) , which might restore the EIC of oxidized ajPI.
Regardless of the explanation for the lack of significant oxidative inactivation of proteinase inhibitors under the conditions we tested, it is noteworthy that a1PI and a2M did not inhibit elastase released from PMN as effectively as they inhibited purified PMN elastase in solution. A likely explanation for this phenomenon is that the inhibitors are partially excluded from the interface between the PMN and the substrate, allowing relatively unrestrained proteolysis to occur in that microenvironment. Our observation of rapid spreading of PMN on the FN substrate supports this explanation. This conclusion was also reached in a recent study (39) 
